Effectiveness of expanded hemodialysis (HDx) in Colombia: A retrospective clinical outcomes study

Renal Therapy Services0 个研究点目标入组 1,098 人开始时间: 2020年8月13日最近更新: 2022年4月4日

适应症

试验速览

2022 Results article in https://doi.org/10.1016/j.xkme.2022.100431 medium cutoff (MCO) versus high-flux (HF) dialysis membranes results (added 23/02/2022)

•1. End stage renal disease
•2. Prevalent HD patient defined as having received HD for 90 days or more at the time of the cohort’s inception (01 September 2017 through 30 November 2017)
•3. Enrolled in the COREXH registry between 01 September 2017 and 30 November 2017, or were treated via conventional high-flux HD during the same time period at the same renal centers, and with the same model of dialysis care
•4. Undergoing HD at least 3 times per week and a minimum duration of 4 hours per session
•5. Received dialysis treatment in a renal clinic that meets water quality standards established by the Association for the Advancement of Medical Instrumentation (AAMI)

•1. High comorbidity measured as Charlson comorbidity Index > 8 and patients who were not expected to survive 6 months
•2. Metastatic disease
•3. Pregnancy
•4. Younger than 18 years old

发起方

Renal Therapy Services